Advertisement
Screener

Kiniksa Pharmaceuticals International, plc (KNSA) Increase (Decrease) in Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

Kiniksa Pharmaceuticals International, plc Increase (Decrease) in Accrued Liabilities

Kiniksa Pharmaceuticals International, plc (KNSA) reported Increase (Decrease) in Accrued Liabilities of -$5.05 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-04-28

  • Kiniksa Pharmaceuticals International, plc increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$5.05M.
  • Kiniksa Pharmaceuticals International, plc increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $19.63M, a 78.54% increase year-over-year.
  • Kiniksa Pharmaceuticals International, plc increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $8.37M, a 22.49% decline year-over-year.
  • Kiniksa Pharmaceuticals International, plc increase (decrease) in accrued liabilities for the quarter ending 2025-06-30 was $13.10M, a 29.79% decline year-over-year.
  • Kiniksa Pharmaceuticals International, plc increase (decrease) in accrued liabilities for fiscal 2025 was $37.50M, a 14.25% decline from fiscal 2024.
  • Kiniksa Pharmaceuticals International, plc increase (decrease) in accrued liabilities for fiscal 2024 was $43.73M, a 158.14% increase from fiscal 2023.
  • Kiniksa Pharmaceuticals International, plc increase (decrease) in accrued liabilities for fiscal 2023 was $16.94M.
  • Kiniksa Pharmaceuticals International, plc increase (decrease) in accrued liabilities for fiscal 2022 was -$3.71M, a 135.87% decline from fiscal 2021.
Period endIncrease (Decrease) in Accrued Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities 9 monthIncrease (Decrease) in Accrued Liabilities 12 month
2026-03-31-$5.05M
10-Q · filed 2026-04-28
$14.58M
derived: sum of 2 quarters · filed 2026-04-28
$22.95M
derived: sum of 3 quarters · filed 2026-04-28
$36.05M
derived: sum of 4 quarters · filed 2026-04-28
2025-12-31$19.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$28.00M
derived: sum of 2 quarters · filed 2026-02-24
$41.09M
derived: sum of 3 quarters · filed 2026-02-24
$37.50M
10-K · filed 2026-02-24
2025-09-30$8.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$21.47M
derived: sum of 2 quarters · filed 2025-10-28
$17.87M
10-Q · filed 2025-10-28
$28.86M
derived: sum of 4 quarters · filed 2026-04-28
2025-06-30$13.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29
$9.50M
10-Q · filed 2025-07-29
$20.50M
derived: sum of 3 quarters · filed 2026-04-28
$31.29M
derived: sum of 4 quarters · filed 2026-04-28
2025-03-31-$3.60M
10-Q · filed 2026-04-28
$7.40M
derived: sum of 2 quarters · filed 2026-04-28
$18.19M
derived: sum of 3 quarters · filed 2026-04-28
$36.85M
derived: sum of 4 quarters · filed 2026-04-28
2024-12-31$10.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$21.79M
derived: sum of 2 quarters · filed 2026-02-24
$40.44M
derived: sum of 3 quarters · filed 2026-02-24
$43.73M
10-K · filed 2026-02-24
2024-09-30$10.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$29.45M
derived: sum of 2 quarters · filed 2025-10-28
$32.74M
10-Q · filed 2025-10-28
$38.02M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30$18.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29
$21.94M
10-Q · filed 2025-07-29
$27.23M
derived: sum of 3 quarters · filed 2026-02-24
$34.83M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31$3.29M
10-Q · filed 2025-04-29
$8.57M
derived: sum of 2 quarters · filed 2026-02-24
$16.18M
derived: sum of 3 quarters · filed 2026-02-24
$30.87M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31$5.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$12.89M
derived: sum of 2 quarters · filed 2026-02-24
$27.59M
derived: sum of 3 quarters · filed 2026-02-24
$16.94M
10-K · filed 2026-02-24
2023-09-30$7.61M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29
$22.30M
derived: sum of 2 quarters · filed 2024-10-29
$11.65M
10-Q · filed 2024-10-29
$7.86M
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30$14.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25
$4.05M
10-Q · filed 2024-07-25
$255.00K
derived: sum of 3 quarters · filed 2025-02-25
$2.23M
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31-$10.65M
10-Q · filed 2024-04-25
-$14.44M
derived: sum of 2 quarters · filed 2025-02-25
-$12.47M
derived: sum of 3 quarters · filed 2025-02-25
-$18.44M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31-$3.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
-$1.82M
derived: sum of 2 quarters · filed 2025-02-25
-$7.79M
derived: sum of 3 quarters · filed 2025-02-25
-$3.71M
10-K · filed 2025-02-25
2022-09-30$1.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
-$4.00M
derived: sum of 2 quarters · filed 2023-11-02
$82.00K
10-Q · filed 2023-11-02
$10.13M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30-$5.97M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
-$1.89M
10-Q · filed 2023-08-01
$8.15M
derived: sum of 3 quarters · filed 2024-02-28
$5.70M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31$4.08M
10-Q · filed 2023-05-04
$14.13M
derived: sum of 2 quarters · filed 2024-02-28
$11.67M
derived: sum of 3 quarters · filed 2024-02-28
$13.35M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31$10.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$7.59M
derived: sum of 2 quarters · filed 2024-02-28
$9.26M
derived: sum of 3 quarters · filed 2024-02-28
$10.34M
10-K · filed 2024-02-28
2021-09-30-$2.46M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
-$784.00K
derived: sum of 2 quarters · filed 2022-11-03
$295.00K
10-Q · filed 2022-11-03
$10.06M
derived: sum of 4 quarters · filed 2023-03-02
2021-06-30$1.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$2.75M
10-Q · filed 2022-08-04
$12.52M
derived: sum of 3 quarters · filed 2023-03-02
$15.70M
derived: sum of 4 quarters · filed 2023-03-02
2021-03-31$1.08M
10-Q · filed 2022-05-05
$10.85M
derived: sum of 2 quarters · filed 2023-03-02
$14.02M
derived: sum of 3 quarters · filed 2023-03-02
$16.94M
derived: sum of 4 quarters · filed 2023-03-02
2020-12-31$9.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02
$12.94M
derived: sum of 2 quarters · filed 2023-03-02
$15.86M
derived: sum of 3 quarters · filed 2023-03-02
$8.80M
10-K · filed 2023-03-02
2020-09-30$3.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$6.09M
derived: sum of 2 quarters · filed 2021-11-04
-$969.00K
10-Q · filed 2021-11-04
$984.00K
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$2.92M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
-$4.15M
10-Q · filed 2021-08-05
-$2.19M
derived: sum of 3 quarters · filed 2022-02-24
-$2.23M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31-$7.06M
10-Q · filed 2021-05-06
-$5.11M
derived: sum of 2 quarters · filed 2022-02-24
-$5.14M
derived: sum of 3 quarters · filed 2022-02-24
-$2.05M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$1.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$1.92M
derived: sum of 2 quarters · filed 2022-02-24
$5.01M
derived: sum of 3 quarters · filed 2022-02-24
$4.64M
10-K · filed 2022-02-24
2019-09-30-$35.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$3.06M
derived: sum of 2 quarters · filed 2020-11-05
$2.69M
10-Q · filed 2020-11-05
$5.53M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$3.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04
$2.72M
10-Q · filed 2020-08-04
$5.57M
derived: sum of 3 quarters · filed 2021-02-25
$6.40M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31-$376.00K
10-Q · filed 2020-05-04
$2.47M
derived: sum of 2 quarters · filed 2021-02-25
$3.30M
derived: sum of 3 quarters · filed 2021-02-25
$9.73M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$2.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$3.68M
derived: sum of 2 quarters · filed 2021-02-25
$10.10M
derived: sum of 3 quarters · filed 2021-02-25
$9.30M
10-K · filed 2021-02-25
2018-09-30$833.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
$7.26M
derived: sum of 2 quarters · filed 2019-11-05
$6.45M
10-Q · filed 2019-11-05
$10.23M
derived: sum of 4 quarters · filed 2019-11-05
2018-06-30$6.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13
$5.62M
10-Q · filed 2019-08-13
$9.40M
derived: sum of 3 quarters · filed 2019-08-13
$9.60M
derived: sum of 4 quarters · filed 2019-08-13
2018-03-31-$807.00K
10-Q · filed 2019-05-07
$2.98M
derived: sum of 2 quarters · filed 2019-05-07
$3.18M
derived: sum of 3 quarters · filed 2019-05-07
2017-12-31$3.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12
$3.99M
derived: sum of 2 quarters · filed 2019-03-12
$4.11M
10-K · filed 2019-03-12
2017-09-30$204.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$323.00K
10-Q · filed 2018-11-06
2017-06-30$119.00K
10-Q · filed 2018-08-06